Primary Care/Hospitalist
RSSArticles
-
Arterial Ischemic Stroke Prevention and Risk Factor Management
MONOGRAPH: Here is the best evidence-based practice for stroke diagnosis, prevention, and risk factor management.
-
Clinical Briefs
In this section: Might a pharmacologic agent that improves insulin resistance be effective in secondary prevention of CV events?; subclinical thyroid disease status associated with mortality in elders; and is there an infectious disease that causes pathological aggression?
-
Buprenorphine Implant for Subdermal Administration (Probuphine)
The FDA has approved the first buprenorphine implant for the treatment of opioid dependence.
-
Optimal Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke
Patients presenting with acute ischemic stroke often take aspirin on a regular basis for prevention of cardiovascular disease. The optimal antiplatelet therapy for secondary prevention has been uncertain in this setting.
-
Prognostic Value of Coronary Calcium on Standard Chest CT Scans
Coronary calcium scan on standard CT scans performed for other indications is of equivalent prognostic value to that seen on ECG-gated coronary studies and should be included in radiology test reports.
-
Does Dysbiosis Cause Multiple Sclerosis?
Increasing evidence suggests that dysbiosis, a disorder in the gut microbiome, leads to autoimmune diseases, including multiple sclerosis.
-
All You Need Is Love, But a Little Chocolate May Benefit, Too
Chocolate consumption may improve liver enzymes and protect against insulin resistance.
-
Why is This Young Athlete’s ECG Abnormal?
-
Clinical Briefs
In this section: glucose variability in type 2 diabetes; bariatric surgery improves pain and function; and two thumbs down for COPD screening.
-
Pimavanserin Tablets (Nuplazid)
Pimavanserin is indicated for the treatment of hallucination and delusions associated with Parkinson's disease psychosis.